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Abstract
Background and purpose We investigated whether university education is more likely in cervical artery dissection (CeAD)-
patients than in age- and sex-matched patients with ischemic stroke (IS) due to other causes (non-CeAD-IS-patients).
Methods Patients from the Cervical Artery Dissection and Ischemic Stroke Patients study with documented self-reported 
profession before onset of IS due to CeAD (n = 715) or non-CeAD causes (n = 631) were analyzed. In the reported profes-
sion, the absence or presence of university education was assessed. Professions could be rated as academic or non-academic 
in 518 CeAD and 456 non-CeAD patients. Clinical outcome at 3 months was defined as excellent if modified Rankin Scale 
was 0–1.
Results University education was more frequent in CeAD-patients (100 of 518, 19.3%) than in non-CeAD-IS-patients (61 of 
456, 13.4%, p = 0.008). CeAD-patients with and without university education differed significantly with regard to smoking 
(39 vs. 57%, p = 0.001) and excellent outcome (80 vs. 66%, p = 0.004). In logistic regression analysis, university educa-
tion was associated with excellent outcome in CeAD-patients (OR 2.44, 95% CI 1.37–5.38) independent of other outcome 
predictors such as age (OR 0.97, 95% CI 0.84–0.99), NIHSS (OR 0.80, 95% CI 0.76–0.84) and local signs (OR 2.77, 95% 
CI 1.37–5.57).
Conclusion We observed a higher rate of university education in patients with CeAD compared with non-CeAD patients 
in our study population. University education was associated with favorable outcome in CeAD-patients. The mechanism 
behind this association remains unclear.
Keywords Cervical artery dissection · Ischemic stroke · Young adults · Outcome · University education · Level of 
education · Socioeconomic status
Introduction
Socioeconomic status (SES) and university education are 
inversely associated with incidence of stroke and mortality 
after stroke [1, 2]. Unfavorable socioeconomic conditions 
even during childhood were statistically related to ischemic 
stroke risk in adulthood [3, 4].
Cervical artery dissection (CeAD) is a common cause of 
stroke in younger adults aged 30–50 years [5, 6]. Therefore, 
the impact of SES and university education might be more 
relevant in this group of working age than in elderly stroke 
patients, the vast majority of whom are retired. However, the 
impact of SES and university education in CeAD is not well 
established and data are sparse and to some extent conflict-
ing [5, 7, 8]. In Grau et al., CeAD was associated with high 
SES, while in Guillon et al. higher education was not [9, 10]. 
Another study on a largely overlapping sample showed that 
there are more physicians among young stroke patients with 
CeAD than among non-CeAD stroke patients [11].
Potential reasons for the association between SES and 
stroke are different distribution of vascular risk factors 
across the society, different awareness of a healthy lifestyle 
and different access to medical care, but a clear causality is 
yet not known [3, 12, 13].
CADISP (Cervical Artery Dissections and Ischemic Stroke 
Patients) Co-investigators are listed in Acknowledgements.
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However, CeAD is associated with lower rates of vas-
cular risk factors and a healthy lifestyle including physical 
activity; this lifestyle might, in contrast, increase the risk of 
CeAD, e.g., due to trauma [5, 14, 15].
Here we aimed to investigate whether (1) an university 
education is more likely in CeAD-patients than in age- and 
sex-matched patients with ischemic stroke or TIA (IS) due 
to other causes (non-CeAD-IS-patients); and (2) whether 
university education is associated with outcome in CeAD 
patients.
Methods
Population
The Cervical Artery Dissection and Ischemic Stroke Patients 
(CADISP) consortium enrolled 762 CeAD-patients with IS 
and 658 non-CeAD-IS-patients [8, 16]. The latter group suf-
fered ischemic stroke (IS) with a cause other than CeAD 
and were frequency-matched to CeAD-patients according to 
age (in 5-year intervals), sex, and center. CADISP enrolled 
patients across 18 centers in eight countries [8, 16].
Level of education, occupational status and income are 
common surrogates for SES [17]. In this study, we compare 
university education vs. non-university education. Univer-
sity education was assessed on the basis of the self-reported 
profession of the patients. Patients’ profession was dichoto-
mized according to whether the current position required a 
university education, i.e., university education, or not. In 74 
cases, information on the profession was missing. In another 
372 of 1346 patients, the documented profession did not 
allow classification into academic vs. non-academic educa-
tion. Among non-classifiable professions were “housewife” 
(n = 42), “retired” (n = 38), or “unemployed” (n = 29) at 
the time of being registered. For this study, the documented 
profession of each patient was re-evaluated blinded to CeAD 
status by all participating CADISP centers to minimize mis-
judgment by the authors with respect to university education 
due to different training routes and different professional 
titles in participating CADISP countries. We further exclude 
CeAD-patients who present only with local signs but with-
out stroke.
Local signs were defined as Horner’s syndrome and/or 
pulsatile tinnitus and/or cranial nerve palsy. Body Mass 
Index was calculated according to the formula: weight (kg)/
height2  (m2). Smoking was defined as never smoker and cur-
rent smoker or former smoker. Severe trauma was defined as 
a trauma that prompted the patient to visit a doctor before 
onset of CeAD/non-CeAD Stroke. All other reported trau-
mas were classified as mild. Outcome at 3 months was 
defined as excellent if the modified Rankin Scale (mRS) 
was 0–1.
Statistical analysis
CeAD-patients and non-CeAD-IS-patients were com-
pared according to the baseline and clinical parameters 
with respect to university education. Normally distributed 
data were presented as mean and standard deviation (SD), 
non-normally distributed data as median and interquartile 
range. For categorical variables, counts and percentages 
were given. Data were compared with Student’s t test, 
Mann–Whitney U test, or Fisher’s exact test where appro-
priate (Table 1). Multivariable analysis was used to ana-
lyze predictors for university education. In the regression 
analysis, all significant parameters of the univariate analy-
sis in Table 1 were included (Table 2). Logistic regression 
analysis was used to analyze predictors of excellent outcome 
in CeAD-patients after adjustment for age, sex, university 
education, NIHSS, local signs, and smoker (Table 3). Crude 
odds ratios (OR) with 95% confidence intervals (95% CI) 
and OR adjusted to potential confounders were calculated. 
A two-sided p value of < 0.05 was considered as statistically 
significant. Statistical analysis was performed with the Sta-
tistical Package for the Social Sciences, SPSS (SPSS Inc., 
23.0 for Windows).
Ethics
The CADISP study protocol (http://clini caltr ials.gov/ct2/
show/NCT00 65796 9) was approved by the relevant local 
authorities of all participating centers and is conducted 
according to the national rules concerning ethics commit-
tee approval and informed consent.
Results
Statement of university education was available in 518 
CeAD-patients and in 456 non-CeAD-IS-patients. Sensi-
tivity analysis showed comparable results in demographic 
and baseline data between patients in whom statement of 
profession was available (n = 974) and in patients in whom 
statement of profession was not available (n = 425) (data 
not shown).
In the regression analysis, there was a non-significant 
association between CeAD and university education (OR 
1.38, 95% CI 0.97–1.96, p = 0.078) adjusted to smoking 
(Table 2).
University education was more frequent in the CeAD 
group (100 of 518, 19.3%) than in the reference group (61 
of 456, 13.4%, p = 0.008). The rate of university education 
in contributing countries ranged between 13.9 and 23.5%. 
CeAD-patients with and without university education 
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differed significantly in terms of smoking (39 vs. 57%, 
p = 0.001), and excellent outcome (80 vs. 6%, p = 0.004) 
(Table 1).
Logistic regression detected university education as an 
independent predictor for excellent outcome in CeAD-
patients (OR 2.44, 95% CI 1.37–5.38). The association 
between university education and outcome was independ-
ent from other significant outcome predictors such as age 
(OR 0.97, 95% CI 0.84–0.99), NIHSS (OR 0.80, 95% 
CI 0.76–0.84), local signs (OR 2.77, 95% CI 1.37–5.57) 
(Table 3).
Discussion
Our analysis showed an association of CeAD and university 
education—independent of vascular risk factors. University 
education was nearly twice as often in the CeAD-patients 
as in the non-CeAD-IS-patients. However, in the regression 
analysis, CeAD and university education were not signifi-
cantly associated when adjusted to smoking. In addition, 
university education was associated with favorable outcome 
in CeAD patients.
Although our study does not allow any causality to be 
inferred, one might speculate that university education might 
be a surrogate for a more active lifestyle including increased 
Table 1  CeAD patients’ and non-CeAD patients’ characteristics according to university education
Numbers are counts and percentages or median and interquartile range
NIHSS National Institute of Health Stroke Scale, TIA transient ischemic attack, BMI Body Mass Index
CeAD patients
n = 518
Non-CeAD patients
n = 456
p
University education
n = 100 (19.3%)
No university education
n = 418 (80.7%)
University education
N = 61 (13.4%)
No university edu-
cation n = 395
(86.6%)
Age 42 (12.2) 43 (9.2) 0.106 38 (10.5) 43.8 (9.7) 0.001
Male sex 40 (40%) 184 (44%) 0.270 42 (69%) 249 (63%) 0.400
Delay in admission to 
hospital (days)
3 (0, 7) 2 (0, 7) 0.380 0.73 (0, 1) 1.43 (0, 1) 0.68
NIHSS admission 2 (0, 6) 2 (0, 7) 0.831 2 (1, 5) 3 (1, 7) 0.15
Stroke 81 (81%) 352 (84.2%) 0.467 61 (100%) 395 (100%)
TIA 19 (19%) 66 (15.8%) 0.360 n.a. n.a.
Local signs 28 (28%) 105 (25%) 0.325 n.a. n.a.
Hypertension 17 (17%) 96 (23%) 0.109 14 (23%) 138 (35%) 0.035
Trauma-mild 37 (37%) 155 (37%) 0.531 6 (9.8%) 41 (10.4%) 1.00
BMI 23.6 (3.4) 24.5 (3.9) 0.149 24.9 (3.5) 25.2 (4.8) 0.99
Migraine 41 (41%) 151 (36%) 0.219 16 (26%) 99 (25%) 0.87
Hyperlipidemia 18 (18%) 79 (19%) 0.520 6 (10%) 122 (31%) 0.001
Diabetes 2 (2%) 8 (2%) 0.577 5 (8%) 28 (7%) 0.641
Smoking 39 (39%) 238 (57%) 0.001 26 (43%) 280 (71%) 0.001
Excellent outcome 80 (80%) 276 (66%) 0.004 44 (72%) 266 (65%) 0.201
Table 2  Regression analysis with university education as dependent 
variable adjusted to CeAD vs. non-CeAD and smoking
OR 95% CI p
CeAD vs. non-
CeAD
1.38 0.97–1.96 0.078
Smoking 0.41 0.29–0.58 < 0.001
Table 3  Regression analysis with excellent outcome at 3  months 
(mRS 0–1) as dependent variable in CeAD-patients
All other variables were entered simultaneously as determinants into 
the logistic regression model
NIHSS National Institute of Health Stroke Scale, BMI Body Mass 
Index
OR 95% CI p
University education 2.44 1.37–5.38 0.027
Higher age 0.97 0.84–0.99 0.038
Male sex 0.61 0.34–1.10 0.09
NIHSS 0.80 0.76–0.84 < 0.001
Local signs 2.77 1.37–5.57 0.004
Smoking 1.40 0.80–2.47 0.244
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physical activity, which might involve frequent sudden head 
movements causing distension of the cervical arteries that 
in turn predispose for CeAD. However, patients with a uni-
versity education did not report mild trauma more often, 
and unfortunately, we do not have data on physical activ-
ity among our patients. The regression analysis for CeAD 
showed a non-significant trend between CeAD and univer-
sity education when adjusted for smoking. This result sug-
gest a more complex relation between CeAD and university 
education and the need for taking smoking as a confounder 
for (un-)healthy lifestyle into account. However, the impact 
of smoking as a well-known risk factor for stroke is most 
probably more relevant in the non-CeAD-IS-group than in 
the CeAD group. Thus, the result of this multivariate analy-
sis might be driven by the impact of smoking in patients 
with strokes caused by other reasons than CeAD.
However, sports and other physical activities may still be 
the explanatory factors for the association between CeAD 
and university education. Patients with university education 
might have better access to medical treatment, and thus even 
minor symptoms such as headache or neck pain might trig-
ger further diagnostics leading to the diagnosis of CeAD. 
As a consequence, CeAD might not be more frequent in 
academics but rather “underdiagnosed” in non-academic 
persons. Another possible bias might be that patients with 
university education are underrepresented in the non-CeAD-
group, because lower socioeconomic status is associated 
with increased risk for vascular events. However, due to 
lack of a control group, we cannot consider with certainty 
whether the rate of patients with university education is rela-
tively higher in CeAD-patients or relatively lower in non-
CeAD-Patients compared with the general population. Both 
possibilities could provide alternative explanations for our 
results.
University education turned out to be an independent 
predictor of excellent outcome after CeAD with an OR of 
2.44 after adjustment for potential confounders. In univari-
ate analysis, an additional 14% of academics had a favora-
ble outcome than non-academics (80 vs. 66%). The associa-
tion of university education and better outcome might be 
driven—again—by better access to medical treatment and 
rehabilitation.
Our study has several limitations. In CADISP, data col-
lection did not aim for detailed information with respect to 
education, profession and other surrogates of SES. Thus, 
dichotomization according to university education is only 
a rough classification. CADISP cannot provide data with 
respect to physical activity, thus all hypotheses about physi-
cal activity as an explanatory factor for CeAD are specu-
lative. However, the strengths of this study are the large 
sample size of CADISP with multinational and multicenter 
data of CeAD patients and a matched reference group with 
ischemic stroke of young adults. Since studies of SES and 
university education and their impact on stroke and espe-
cially on CeAD are sparse, our analysis yielded some new 
findings.
Conclusion
University education was associated with CeAD in ischemic 
stroke of young adults along with a more favorable outcome 
in our study population. However, underlying mechanisms 
are as yet unknown and the impact of socioeconomic factors 
in CeAD and in ischemic stroke in general requires further 
investigations.
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